As the medication's appetite-suppressing effects wane, many patients experience a return of previous hunger patterns, which may lead to weight regain if dietary habits are not maintained
FAQ Liraglutide | Reviews Liraglutide is a GLP-1 receptor agonist that is approved for the treatment of type 2 diabetes and as a weight loss agent in overweight and obese individuals
Brain uptake pharmacokinetics of incretin receptor agonists showing promise as Alzheimer's and Parkinson's disease therapeutics
GLP-1 medications are not a treatment for the thyroid itself, but they can be a powerful ally in managing the metabolic "stalling," insulin resistance, and weight gain that frequently accompany an underactive thyroid
Certain cancers, like lymphoma, metastatic head and neck cancers, or salivary gland tumors, may present as a persistent, painless neck mass
Notably, the NHS in the UK now covers both Wegovy and Mounjaro for obesity treatment